Delivery Order SPE2DB20D9127-SPE2DB25FPRK4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $32,966.42 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Cabometyx 40 mg tablets (30-count units). This firm fixed-price delivery order, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The...
- The U.S. Defense Logistics Agency awarded a delivery order valued at $16,483.21 to DMS Pharmaceutical Group Inc. for the supply of Cabometyx 40 mg tablets (30-count units). This award, issued on August 19, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 20, 2025, and will be performed at the contractor's facility in Park Ridge, Illinois. The contract utilizes no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $33,265.08 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Cabometyx 20 mg tablets (30-count units). This firm fixed-price delivery order, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a direct pharmaceutical supply fulfillment under DLA's pharmaceutical distribution operations. DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $16,483.21 by the Defense Logistics Agency on September 3, 2025, for the supply of Cabometyx 40 mg tablets (30-count units). This firm fixed-price delivery order, with an ultimate completion date of September 4, 2025, was issued without a set-aside designation. The award is issued under DMS Pharmaceutical Group's existing single-award...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $16,483.21 by the Defense Logistics Agency (DLA) for the supply of Cabometyx 40 mg tablets (30-count packages). This firm fixed-price delivery order, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a discrete purchase under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $83,162.70 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Cabometyx 20 mg tablets (30-count units). This delivery order was issued without a set-aside designation on August 11, 2025, with an ultimate completion date of August 12, 2025. The award represents a discrete purchase order under DMS Pharmaceutical Group's larger...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order, contract SPE2DB24FSW72, to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $15,409.02 order is for the supply of Cabometyx 40 mg tablets. This delivery order is part of a larger indefinite-delivery vehicle (IDV), contract SPE2DB22D9367, with DMS Pharmaceutical Group that has a ceiling value of up to $4,999,999 through 2025. The IDV allows DLA to issue delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency (DLA) on August 25, 2025, for Cabometyx 40 mg tablets (30-count units). This firm fixed-price delivery order, valued at approximately $33k, represents a single purchase action issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $500M vehicle valid...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,434.34 by the Defense Logistics Agency on July 30, 2025, for the supply of Cabometyx 60 mg tablets (30-count units). The delivery order is issued without a set-aside designation and is scheduled for completion by July 31, 2025. This award falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery...
- This is a $33,265.08 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of 4567795377 CABOMETYX 20 MG TABLET 30S, a pharmaceutical product, with a period of performance through April 4, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the...
- SPE2DB20D9127Indefinite Delivery Contract
- SPE2DB20D9127-SPE2DB25FPRK4Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $16,483.21 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Cabometyx 40 mg tablets (30-count units). This firm fixed-price delivery order, issued on September 10, 2025, with an ultimate completion date of September 11, 2025, represents a typical transactional procurement under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The delivery order carries no set-aside designation, allowing the vendor to compete on its merits as a qualified federal pharmaceutical supplier. This delivery order falls under DMS Pharmaceutical Group's existing $499.999 billion single-award IDC with the DLA under the SPE2DB program, which remains valid through November 2026. The IDC framework enables the Defense Logistics Agency to issue firm fixed-price delivery orders for pharmaceutical products supporting medical supply needs across military health facilities worldwide. Cabometyx is a branded prescription oncology medication, consistent with DMS Pharmaceutical Group's demonstrated portfolio of specialty pharmaceutical deliveries, which includes cancer treatments, biologics, and other critical medications serving Department of Defense healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.5k | 9/10/25 |